{"id":68745,"date":"2026-02-20T17:22:38","date_gmt":"2026-02-20T17:22:38","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68745"},"modified":"2026-05-21T07:14:12","modified_gmt":"2026-05-21T07:14:12","slug":"bpc-157","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/bpc-157\/","title":{"rendered":"BPC-157"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">R\u0103spuns rapid \u2014 Ce este BPC-157?<\/h3>\n<p style=\"margin: 0;\"><strong>BPC-157<\/strong> (Body Protection Compound 157) este un pentadecapeptid sintetic cu 15 aminoacizi, derivat dintr-o protein\u0103 gastric\u0103 protector\u0103. \u00cen cercet\u0103rile preclinice publicate, a demonstrat efecte consistente asupra recuper\u0103rii tendonului, ligamentului, intestinului, mu\u0219chiului \u0219i \u021besutului vascular, prin intermediul VEGF, oxidului nitric \u0219i semnaliz\u0103rii receptorului de hormon de cre\u0219tere. Furnizat \u00een flacoane liofilizate de la 2 mg p\u00e2n\u0103 la 10 mg, destinat exclusiv cercet\u0103rilor de laborator.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Peptide liofilizate pentru cercetare \u00b7 puritate HPLC \u226599% (certificat de analiz\u0103 la cerere) \u00b7 Ambalaj discret stabil la temperatur\u0103 \u00b7 Curierat worldwide de peptide \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specifica\u021bii<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detaliu<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Num\u0103r CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">137525-51-0<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formula molecular\u0103<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>62<\/sub>H<sub>98<\/sub>N<sub>16<\/sub>O<sub>22<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Greutate molecular\u0103<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1419.55 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Secven\u021b\u0103<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Form\u0103<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Pulbere liofilizat\u0103 (sau a\u0219a cum este furnizat)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Puritate<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificat prin HPLC, COA la cerere)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Depozitare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizat: 2\u20138\u00b0C (frigider) pentru stocul de lucru; \u221220\u00b0C pentru depozitarea pe termen lung a vialelor nefolosite. Reconstituit: 2\u20138\u00b0C, utilizat \u00een ~30 de zile. Proteja\u021bi de lumin\u0103. Nu \u00eenghe\u021ba\u021bi-decongela\u021bi solu\u021bia reconstituit\u0103.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilitate<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Ap\u0103 bacteriostatic\u0103 (recomandat\u0103) sau ap\u0103 steril\u0103 pentru perioade mai scurte de utilizare<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Utilizare \u00een cercetare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Doar pentru utilizare \u00een cercetare de laborator. Nu este destinat pentru uz diagnostic sau terapeutic uman sau veterinar.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Ce este BPC-157?<\/h2>\n<p><strong>BPC-157<\/strong> este abrevierea pentru <strong>Body Protection Compound 157<\/strong>, un pentadecapeptid sintetic cu 15 aminoacizi, izolat ini\u021bial ca fragment al unei proteine protectoare mai mari g\u0103site \u00een sucul gastric uman. Spre deosebire de majoritatea peptidelor, este stabil \u00een acid gastric, ceea ce l-a f\u0103cut un subiect frecvent al cercet\u0103rilor de administrare oral\u0103 pe modele de roz\u0103toare, al\u0103turi de ruta subcutanat\u0103 mai comun\u0103. BPC-157 este unul dintre peptidele cele mai studiate \u00een literatura preclinic\u0103 \u00een domeniul vindec\u0103rii, cu lucr\u0103ri publicate care acoper\u0103 tendonul, ligamentul, bariera intestinal\u0103, mu\u0219chiul scheletic, osul \u0219i \u021besutul vascular.<\/p>\n<p>Secven\u021ba peptidic\u0103 este GEPPPGKPADDAGLV, cu o greutate molecular\u0103 de aproximativ 1.419 Da \u0219i formula empiric\u0103 C. Este furnizat sub form\u0103 de pulbere liofilizat\u0103 de \u00eenalt\u0103 puritate, pentru reconstituire cu ap\u0103 bacteriostatic\u0103. BPC-157 este<sub>62<\/sub>H<sub>98<\/sub>N<sub>16<\/sub>O<sub>22<\/sub>. \u0219i nu este destinat pentru diagnostic sau terapie uman\u0103 sau veterinar\u0103. Pentru o analiz\u0103 detaliat\u0103 a mecanismului, detalii ale studiilor publicate \u0219i considera\u021bii privind dozarea \u00een cercetare, consulta\u021bi sec\u021biunea noastr\u0103 complet\u0103 <strong>destinat doar pentru cercetare de laborator<\/strong> Mecanismul de ac\u021biune \u2014 Trei c\u0103i de vindecare suprapuse <a href=\"https:\/\/medsbase.com\/ro\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157 research guide<\/a>.<\/p>\n<h2>Ceea ce diferen\u021biaz\u0103 BPC-157 de peptidele cu o singur\u0103 cale de ac\u021biune este<\/h2>\n<p>What differentiates BPC-157 from single-pathway peptides is its <strong>activitate simultan\u0103 pe trei c\u0103i de semnalizare distincte<\/strong>, fiecare contribuind la fenotipul de recuperare tisular\u0103 observat \u00een cercet\u0103rile publicate:<\/p>\n<ul>\n<li><strong>Angiogenez\u0103 \/ upregulare VEGF<\/strong> \u2014 BPC-157 upreguleaz\u0103 expresia receptorului 2 pentru factorul de cre\u0219tere vascular endothelial (VEGFR2) \u00een \u021besutul lezat, promov\u00e2nd formarea de noi capilare. Acest lucru \u00eembun\u0103t\u0103\u021be\u0219te perfuzia local\u0103 la locurile de repara\u021bie, pasul limitativ \u00een vindecarea tendonului, ligamentului \u0219i mu\u0219chiului.<\/li>\n<li><strong>Calea oxidului nitric (NO)<\/strong> \u2014 BPC-157 stimuleaz\u0103 activitatea oxidului nitric sintetazei endoteliale (eNOS) \u0219i protejeaz\u0103 endoteliul vascular \u00eempotriva daunelor oxidativ. \u00cen modelele rodent de hipertensiune portal\u0103, vasoconstric\u021bie sistemic\u0103 \u0219i ulcere gastrice, acest efect este central pentru ac\u021biunea protector\u0103 a compusului.<\/li>\n<li><strong>Upregularea receptorului de hormon de cre\u0219tere<\/strong> \u2014 BPC-157 cre\u0219te expresia receptorului de hormon de cre\u0219tere (GHR) pe fibroblaste \u0219i tenocite, sporind sinteza de colagen tip I. Acest mecanism este considerat a sta la baza c\u00e2\u0219tigurilor de rezisten\u021b\u0103 a tendonului observate \u00een modelele de sec\u021bionare a tendonului lui Ahile \u0219i a ligamentului colateral medial.<\/li>\n<\/ul>\n<p>Deoarece aceste trei c\u0103i converg asupra \u021besutului lezat, BPC-157 produce o recuperare mai rapid\u0103 \u0219i mai complet\u0103 dec\u00e2t interven\u021biile pe o singur\u0103 cale \u00een acelea\u0219i modele. De asemenea, este remarcabil de bine tolerat \u00een gama de doze publicate, cu semnalizare off-target minim\u0103 raportat\u0103 \u00een cercet\u0103rile toxicologice.<\/p>\n<h2>Aplica\u021bii de Cercetare Publicate<\/h2>\n<p>BPC-157 este utilizat \u00een contexte de cercetare de laborator care investigheaz\u0103:<\/p>\n<ul>\n<li><strong>Recuperarea leziunilor de tendon \u0219i ligament<\/strong> \u2014 modele rodent de sec\u021bionare a tendonului lui Ahile, ruptur\u0103 a ligamentului colateral medial, ruptur\u0103 a man\u0219etei rotatorii (Chang et al., J Appl Physiol 2011; Staresinic et al., J Orthop Res 2003)<\/li>\n<li><strong>Integritatea barierii intestinale \u0219i cercetarea ulcerului<\/strong> \u2014 modele de ulcer gastric, colit\u0103 \u0219i boal\u0103 inflamatorie intestinal\u0103; originea gastric\u0103 a BPC-157 este relevant\u0103 mecanic aici (Sikiric et al., Curr Med Chem 2011)<\/li>\n<li><strong>Regenerarea mu\u0219chilor scheletici<\/strong> \u2014 cinetica recuper\u0103rii post-traumatice, proliferarea mioblastelor \u0219i cercetarea form\u0103rii miotuburilor<\/li>\n<li><strong>Cercetare articular\u0103 \u0219i de cartilaj<\/strong> \u2014 modele rodentine de osteoartrit\u0103, compozi\u021bia matricei cartilaginoase, inflama\u021bia sinovial\u0103<\/li>\n<li><strong>Angiogenez\u0103 vascular\u0103<\/strong> \u2014 formarea de noi capilare \u0219i perfuzia la locurile de \u021besut lezat<\/li>\n<li><strong>Vindecare osoas\u0103<\/strong> \u2014 formarea calusului fracturii \u00een modelele de cercetare de osteotomie \u0219i defect osos<\/li>\n<li><strong>Cercetare comparativ\u0103 a recuper\u0103rii<\/strong> \u2014 compararea cu alte peptide de vindecare, \u00een special <a href=\"https:\/\/medsbase.com\/ro\/tb-500\/\">TB-500 (Thymosin Beta-4)<\/a> ca comparatorul canonic sistemic de vindecare. Vezi <a href=\"https:\/\/medsbase.com\/ro\/bpc-157-vs-tb-500-comparison-guide\/\">BPC-157 vs TB-500 comparison<\/a> pentru o compara\u021bie detaliat\u0103.<\/li>\n<\/ul>\n<p>Pentru o perspectiv\u0103 mai larg\u0103 asupra locului pe care \u00eel ocup\u0103 BPC-157 \u00een domeniul peptidelor de vindecare, consulta\u021bi <a href=\"https:\/\/medsbase.com\/ro\/best-peptides-for-muscle-recovery\/\">cele mai bune peptide pentru recuperarea muscular\u0103<\/a> articolul tematic \u0219i <a href=\"https:\/\/medsbase.com\/ro\/ghk-cu\/\">peptidul de cupru GHK-Cu<\/a> ca un compus complementar de cercetare anti-\u00eemb\u0103tr\u00e2nire. R\u0103sfoi\u021bi \u00eentregul <a href=\"https:\/\/medsbase.com\/ro\/peptides\/\">de peptide de cercetare<\/a> pentru compu\u0219i \u00eenrudi\u021bi.<\/p>\n<h2>Concentra\u021bii \u0219i doze disponibile<\/h2>\n<p>MedsBase stocheaz\u0103 BPC-157 \u00een urm\u0103toarele dimensiuni de flacoane liofilizate. Fiecare variant\u0103 este livrat\u0103 \u00een formate de 10 flacoane, 20 de flacoane \u0219i 30 de flacoane, cu instruc\u021biuni complete de reconstituire:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Putere flacon<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caz de utilizare tipic<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dimensiuni pachet<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>2 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Protocoale de cercetare scurte, dozaj pilot, titrare<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 sau 30 de flacoane<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Concentra\u021bie standard de cercetare, cea mai comandat\u0103<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 sau 30 de flacoane<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Protocoale de cercetare extinse, cel mai mic cost pe mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 sau 30 de flacoane<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Toate cele trei concentra\u021bii sunt \u00een aceea\u0219i form\u0103 chimic\u0103 (pudr\u0103 liofilizat\u0103, puritate HPLC \u226599%). Flacoanele cu mg mai mari necesit\u0103 volume mai mici de reconstituire pe unitate de doz\u0103, ceea ce este util atunci c\u00e2nd cercet\u0103torii doresc s\u0103 minimizeze volumul de injectare \u00een protocoalele pentru roz\u0103toare.<\/p>\n<h2>Cum se compar\u0103 \u2014 BPC-157 vs TB-500<\/h2>\n<p>BPC-157 \u0219i <a href=\"https:\/\/medsbase.com\/ro\/tb-500\/\">TB-500<\/a> sunt cele dou\u0103 peptide de vindecare cele mai citate \u00een cercetare. Ele sunt adesea studiate \u00een paralel deoarece ac\u021bioneaz\u0103 prin mecanisme complementare, \u00een mare m\u0103sur\u0103 nesuprapuse. Multe protocoale preclinice le combin\u0103 \u00een loc s\u0103 le foloseasc\u0103 separat.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criteriu<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">BPC-157<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">TB-500 (Thymosin Beta-4)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Lungime<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">15 aminoacizi (pentadecapeptid)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">43 de aminoacizi (peptid timic)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Mecanism primar<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">VEGF + NO + upregulare receptor GH<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sechestrare G-actin\u0103, migrare celular\u0103<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Distribu\u021bie<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Mai localizat la locul de injectare<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sistemic, se distribuie pe larg<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Doza tipic\u0103 de cercetare<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">250\u2013500 mcg, 1\u20132 ori pe zi<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\u20132,5 mg, de 2 ori pe s\u0103pt\u0103m\u00e2n\u0103<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Cel mai puternic semnal de cercetare<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tendon, ligament, barier\u0103 intestinal\u0103<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Cardiac, mu\u0219chi sistemic, vascular<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Stivuire<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Folosit frecvent \u00een combina\u021bie cu TB-500 \u00een cercetare<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Folosit frecvent \u00een combina\u021bie cu BPC-157 \u00een cercetare<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Pentru o compara\u021bie metodologic\u0103 complet\u0103, inclusiv protocoale de dozare \u0219i criterii de alegere, citi\u021bi <a href=\"https:\/\/medsbase.com\/ro\/bpc-157-vs-tb-500-comparison-guide\/\">BPC-157 vs TB-500: care peptid de vindecare pentru obiectivul t\u0103u de recuperare<\/a>.<\/p>\n<h2>Depozitare \u0219i reconstituire<\/h2>\n<p><strong>\u00cenainte de reconstituire:<\/strong> p\u0103stra\u021bi flacoanele liofilizate la frigider la 2\u20138 \u00b0C \u00een ambalajul original. BPC-157 liofilizat este stabil \u00een aceste condi\u021bii pentru p\u00e2n\u0103 la 36 de luni. Evita\u021bi ciclurile de \u00eenghe\u021b-dezghe\u021b ale pulberii.<\/p>\n<p><strong>Procedura de reconstituire:<\/strong> injecta\u021bi ap\u0103 bacteriostatic\u0103 pe peretele lateral al flaconului de peptid\u0103 (nu direct pe tortul liofilizat) conform tabelului de dilu\u021bie de mai sus. \u00cenv\u00e2rti\u021bi u\u0219or \u2014 nu <strong>prime\u0219te,<\/strong> zg\u00e2l\u021b\u00e2i\u021bi \u2014 \u0219i a\u0219tepta\u021bi 2\u20135 minute pentru dizolvare complet\u0103. O solu\u021bie reconstituit\u0103 corect ar trebui s\u0103 fie limpede \u0219i incolor\u0103.<\/p>\n<p><strong>Dup\u0103 reconstituire:<\/strong> p\u0103stra\u021bi la frigider la 2\u20138 \u00b0C \u0219i utiliza\u021bi \u00een termen de 30 de zile pentru stabilitate optim\u0103. Nu congela\u021bi solu\u021bia reconstituit\u0103 \u2014 ciclurile de \u00eenghe\u021b-dezghe\u021b degradeaz\u0103 integritatea peptidului. Elimina\u021bi orice flacon care prezint\u0103 tulbureal\u0103, precipitat sau decolorare.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3>Pentru ce este utilizat BPC-157 \u00een cercetare?<\/h3>\n<p>BPC-157 este utilizat \u00een cercetarea de laborator care investigheaz\u0103 vindecarea tendonelor \u0219i ligamentelor, integritatea barierei intestinale, recuperarea mu\u0219chilor scheletici, angiogeneza vascular\u0103, semnalizarea antiinflamatoare \u0219i vindecarea osoas\u0103. Acesta este <strong>prime\u0219te,<\/strong> aprobat de FDA \u0219i este v\u00e2ndut aici strict pentru uz \u00een cercetare de laborator.<\/p>\n<h3>Care este diferen\u021ba dintre BPC-157 \u0219i TB-500?<\/h3>\n<p>BPC-157 este un pentadecapeptid de 15 aminoacizi derivat din sucul gastric, ac\u021bion\u00e2nd \u00een principal local prin c\u0103ile VEGF, oxidul nitric \u0219i receptorii hormonului de cre\u0219tere. TB-500 este un peptid timic de 43 de aminoacizi care ac\u021bioneaz\u0103 sistemic prin legarea G-actinei \u0219i migra\u021bia celular\u0103. Cele dou\u0103 sunt adesea co-administrate \u00een cercetare deoarece mecanismele lor sunt complementare, nu suprapuse.<\/p>\n<h3>Care este doza tipic\u0103 de cercetare pentru BPC-157?<\/h3>\n<p>Protocoalele preclinice publicate utilizeaz\u0103 de obicei 250\u2013500 mcg pe administrare, administrate o dat\u0103 sau de dou\u0103 ori pe zi pentru cicluri de 4\u20138 s\u0103pt\u0103m\u00e2ni. Un flacon de 5 mg reconstituit cu 2,0 mL ap\u0103 bacteriostatic\u0103 produce 2,5 mg\/mL \u2014 10 grada\u021bii pe o sering\u0103 U-100 echivaleaz\u0103 cu 250 mcg.<\/p>\n<h3>Este BPC-157 aprobat de FDA?<\/h3>\n<p>Nu. BPC-157 nu este aprobat de FDA, EMA, MHRA sau orice alt regulator pentru utilizare terapeutic\u0103 uman\u0103. Tot BPC-157 v\u00e2ndut de furnizori pentru uz exclusiv \u00een cercetare este destinat investiga\u021biilor de laborator \u0219i nu trebuie administrat persoanelor.<\/p>\n<h3>Cum trebuie depozitat BPC-157?<\/h3>\n<p>Flacoane liofilizate: la frigider la 2\u20138 \u00b0C \u00een ambalajul original, stabil p\u00e2n\u0103 la 36 de luni. Solu\u021bia reconstituit\u0103: la frigider la 2\u20138 \u00b0C, utilizat\u0103 \u00een termen de 30 de zile. Nu \u00eenghe\u021ba\u021bi solu\u021bia reconstituit\u0103 \u2014 ciclurile de \u00eenghe\u021bare-dezghe\u021bare degradeaz\u0103 peptidul.<\/p>\n<h3>Cum se reconstituie BPC-157?<\/h3>\n<p>Urma\u021bi tabelul de referin\u021b\u0103 pentru reconstituire de mai sus. Ad\u0103uga\u021bi ap\u0103 bacteriostatic\u0103 pe peretele lateral al flaconului (nu direct pe praful liofilizat), \u00eenv\u00e2rti\u021bi u\u0219or \u0219i a\u0219tepta\u021bi 2\u20135 minute pentru dizolvare complet\u0103. Nu <strong>prime\u0219te,<\/strong> agita\u021bi flaconul.<\/p>\n<h3>Ce doze stocheaz\u0103 MedsBase?<\/h3>\n<p>MedsBase comercializeaz\u0103 BPC-157 \u00een flacoane liofilizate de 2 mg, 5 mg \u0219i 10 mg. Fiecare concentra\u021bie este disponibil\u0103 \u00een pachete de 10, 20 sau 30 de flacoane. Toate flacoanele au o puritate HPLC de 99%+ \u0219i sunt furnizate cu certificat de analiz\u0103 la cerere.<\/p>\n<h3>Pot fi utilizate \u00eempreun\u0103 BPC-157 \u0219i TB-500 \u00een cercetare?<\/h3>\n<p>Da. BPC-157 \u0219i TB-500 sunt frecvent administrate \u00eempreun\u0103 \u00een cercetarea preclinic\u0103 deoarece mecanismele lor sunt complementare. BPC-157 ac\u021bioneaz\u0103 predominant local prin upregularea factorilor de cre\u0219tere; TB-500 ac\u021bioneaz\u0103 sistemic prin legarea G-actinei \u0219i migra\u021bia celular\u0103. Protocoalele combinate sunt descrise \u00een <a href=\"https:\/\/medsbase.com\/ro\/bpc-157-vs-tb-500-comparison-guide\/\">ghidul nostru comparativ<\/a>.<\/p>\n<h3>BPC-157 provoac\u0103 efecte adverse \u00een cercetare?<\/h3>\n<p>Cercet\u0103rile preclinice publicate pe specii de roz\u0103toare au raportat un profil de siguran\u021b\u0103 remarcabil la dozele tipice de cercetare, f\u0103r\u0103 semnale consistente de efecte off-target \u0219i o bun\u0103 tolerabilitate. Datele privind siguran\u021ba pe termen lung la om nu sunt disponibile deoarece studiile clinice nu au fost finalizate.<\/p>\n<h3>Care este diferen\u021ba dintre BPC-157 oral \u0219i injectabil \u00een cercetare?<\/h3>\n<p>BPC-157 este neobi\u0219nuit de stabil \u00een acidul gastric datorit\u0103 originii sale din sucul gastric, astfel \u00eenc\u00e2t administrarea oral\u0103 este fezabil\u0103 \u00een protocoalele pe roz\u0103toare (spre deosebire de majoritatea peptidelor). Injectarea subcutanat\u0103 r\u0103m\u00e2ne cea mai comun\u0103 rut\u0103 de cercetare din literatur\u0103 deoarece produce concentra\u021bii plasmatice mai reproductibile.<\/p>\n<h3>Care este timpul de \u00eenjum\u0103t\u0103\u021bire al BPC-157?<\/h3>\n<p>\u00cen cercet\u0103rile preclinice, BPC-157 are o semivid\u0103 plasmatic\u0103 estimat\u0103 de aproximativ 4 ore dup\u0103 administrare subcutanat\u0103. Studiile pe cale oral\u0103 \u00een modelele rodentine sugereaz\u0103 o clearance sistemic\u0103 mai scurt\u0103, dar efecte locale sus\u021binute \u00een tractul gastrointestinal, atribuite stabilit\u0103\u021bii neobi\u0219nuite la acizi a peptidului.<\/p>\n<h3>C\u00e2t dureaz\u0103 p\u00e2n\u0103 apar efectele BPC-157 \u00een cercet\u0103rile preclinice?<\/h3>\n<p>Majoritatea studiilor preclinice care utilizeaz\u0103 BPC-157 \u00een modele de leziuni ale tendonului, ligamentelor \u0219i intestinului raporteaz\u0103 modific\u0103ri m\u0103surabile la nivel tisular \u00een 7\u201314 zile. Durata variaz\u0103 \u00een func\u021bie de modelul de cercetare, severitatea leziunii, calea de administrare \u0219i doza utilizat\u0103 \u00een designul studiului.<\/p>\n<h3>Pot comanda BPC-157 pentru transport interna\u021bional?<\/h3>\n<p>Da. MedsBase expediaz\u0103 BPC-157 \u00een \u00eentreaga lume prin re\u021beaua noastr\u0103 dedicat\u0103 de transport de peptide. Comenzile care con\u021bin doar peptide se calific\u0103 pentru serviciul nostru separat de transport de peptide. Toate comenzile sunt expediate \u00een ambalaje cu control termic \u0219i cu urm\u0103rire complet\u0103.<\/p>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-peptide-healing-stack\">Protocoalele cu BPC-157 pentru recuperarea tendonului, ligamentelor \u0219i \u021besuturilor moi \u00eel asociaz\u0103 de obicei cu TB-500 pentru efecte sinergice angiogene + citoscheletale; pentru regimul combinat, consulta\u021bi <a href=\"\/ro\/peptide-healing-stack\/\">Peptide Healing Stack (BPC-157 5 mg + TB-500 5 mg + ap\u0103 bacteriostatic\u0103)<\/a> cu ambele flacoane liofilizate \u0219i ap\u0103 de reconstituire \u00eentr-un singur colet la tariful de transport $0 pentru peptide.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Alte peptide pentru cercetare \u00een recuperare \u0219i performan\u021b\u0103<\/h2>\n<ul>\n<li><a href=\"\/ro\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Fragment de Thymosin Beta-4 \u2014 cercetare \u00een recuperarea \u021besuturilor moi \u0219i vasculare<\/li>\n<li><a href=\"\/ro\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Agonist selectiv de ghrelin\u0103 \u2014 puls de hormon de cre\u0219tere f\u0103r\u0103 cortizol\/prolactin\u0103<\/li>\n<li><a href=\"\/ro\/cjc-1295-with-dac\/\"><strong>CJC-1295 cu DAC<\/strong><\/a> \u2014 Analog GHRH cu timp de \u00eenjum\u0103t\u0103\u021bire prelungit<\/li>\n<li><a href=\"\/ro\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Peptid de cupru \u2014 cercetare \u00een regenerarea pielii \u0219i a \u021besutului conjunctiv<\/li>\n<li><a href=\"\/ro\/igf-1-lr3\/\"><strong>IGF-1 LR3<\/strong><\/a> \u2014 Analog Long-R3 IGF-1 \u2014 cercetare anabolic\u0103 \/ regenerativ\u0103<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Lectur\u0103 suplimentar\u0103<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Afla\u021bi cercetarea din spatele acestui peptid<\/strong><\/p>\n<p style=\"margin: 0;\">Cititi ghidul nostru complet bazat pe dovezi: <a href=\"https:\/\/medsbase.com\/ro\/bpc-157-peptide-healing-recovery-guide\/\"><strong>BPC-157 \u2014 mecanism, date din studii \u0219i perspective<\/strong><\/a>. Acoper\u0103 mecanismul de ac\u021biune, datele din studiile publicate, gamele tipice de dozare pentru cercetare, protocoale de reconstituire, considera\u021bii de combinare \u0219i note de siguran\u021b\u0103\/contraindica\u021bii.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Sus\u021bine regenerarea celular\u0103<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te modelarea \u021besuturilor<br \/>\n\u2705 Stimuleaz\u0103 activitatea fibroblastelor<br \/>\n\u2705 Activeaz\u0103 semnalizarea angiogenic\u0103<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te stabilitatea matricei extracelulare<\/p>\n<p><strong>BPC-157<\/strong> con\u021bine compus peptidic sintetic.<\/p>","protected":false},"featured_media":70942,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5440,5430,5441],"class_list":{"0":"post-68745","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptides","7":"product_tag-bpc-157","8":"product_tag-bpc-157-peptide","9":"product_tag-peptide","11":"first","12":"instock","13":"shipping-taxable","14":"purchasable","15":"product-type-variable","16":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/68745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=68745"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/70942"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=68745"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=68745"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=68745"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=68745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}